VGA
NVNO

Vanguard Global Advisers’s enVVeno Medical NVNO Stock Holding History

Vanguard Global Advisers’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$780 Buy
+77
New +$843 ﹤0.01% 3644

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Global Advisers's NVNO Position: Q1 2026 in Review

Vanguard Global Advisers opened a new position in enVVeno Medical (NVNO) in Q1 2026: 77 shares worth $780. The stake represents ﹤0.01% of the portfolio and ranks #3644 among its holdings.

17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • Vanguard Global Advisers held 77 shares of enVVeno Medical worth $780 as of Q1 2026.
  • enVVeno Medical was a new Vanguard Global Advisers position in Q1 2026.
  • enVVeno Medical made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q1 2026, its #3644 holding.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Vanguard Global Advisers's 13F filing for Q1 2026, filed 8 May 2026.